619 related articles for article (PubMed ID: 33374908)
1. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy.
Quadri Z; Elsherbini A; Bieberich E
Pharmacol Res; 2022 Jan; 175():105980. PubMed ID: 34863822
[TBL] [Abstract][Full Text] [Related]
4. Exosome: From biology to drug delivery.
Baruah H; Sarma A; Basak D; Das M
Drug Deliv Transl Res; 2024 Jun; 14(6):1480-1516. PubMed ID: 38252268
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles as Therapeutic Agents in Systemic Lupus Erythematosus.
Perez-Hernandez J; Redon J; Cortes R
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28350323
[TBL] [Abstract][Full Text] [Related]
7. Potential therapeutic applications of exosomes in different autoimmune diseases.
Xu H; Jia S; Xu H
Clin Immunol; 2019 Aug; 205():116-124. PubMed ID: 31228581
[TBL] [Abstract][Full Text] [Related]
8. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
[TBL] [Abstract][Full Text] [Related]
10. Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications.
Amiri A; Bagherifar R; Ansari Dezfouli E; Kiaie SH; Jafari R; Ramezani R
J Transl Med; 2022 Mar; 20(1):125. PubMed ID: 35287692
[TBL] [Abstract][Full Text] [Related]
11. Exosomes: Therapy delivery tools and biomarkers of diseases.
Barile L; Vassalli G
Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
[TBL] [Abstract][Full Text] [Related]
12. The role of exosome in autoimmune connective tissue disease.
Zhu T; Wang Y; Jin H; Li L
Ann Med; 2019 Mar; 51(2):101-108. PubMed ID: 30961395
[TBL] [Abstract][Full Text] [Related]
13. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review.
Chen Z; Xiong M; Tian J; Song D; Duan S; Zhang L
J Nanobiotechnology; 2024 Jan; 22(1):18. PubMed ID: 38172932
[TBL] [Abstract][Full Text] [Related]
15. Engineering of extracellular vesicles as drug delivery vehicles.
Kim SM; Kim HS
Stem Cell Investig; 2017; 4():74. PubMed ID: 29057246
[TBL] [Abstract][Full Text] [Related]
16. Recent advances of exosomes in immune modulation and autoimmune diseases.
Tan L; Wu H; Liu Y; Zhao M; Li D; Lu Q
Autoimmunity; 2016 Sep; 49(6):357-365. PubMed ID: 27259064
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus.
Perez-Hernandez J; Cortes R
Dis Markers; 2015; 2015():613536. PubMed ID: 26435565
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
